The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
Open accessAbstract
The type I alpha/beta interferons (IFN-α/β) are known to play an important role in host defense against influenza A virus infection, but we have now discovered that the recently identified type III IFNs (IFN-λ) constitute the major response to intranasal infection with this virus. Type III IFNs were present at much higher levels than type I IFNs in the lungs of infected mice, and the enhanced susceptibility of STAT2 −/− animals demonstrated that only signaling through the IFN-α/β or IFN-λ pathways was sufficient to mediate protection. This finding offers a possible explanation for the similar levels of antiviral protection found in wild-type (WT) mice and in animals lacking a functional type I IFN receptor (IFNAR −/− ) but also argues that our current understanding of type III IFN induction is incomplete. While murine IFN-λ production is thought to depend on signaling through the type I IFN receptor, we demonstrate that intranasal influenza A virus infection leads to the robust type III IFN induction in the lungs of both WT and IFNAR −/− mice. This is consistent with previous studies showing that IFNAR-mediated protection is redundant for mucosal influenza virus infection and with data showing that the type III IFN receptor is expressed primarily by epithelial cells. However, the overlapping effects of these two cytokine families are limited by their differential receptor expression, with a requirement for IFN-α/β signaling in combating systemic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., & Donnelly, R. P. (2003) · Nature Immunology · doi:10.1038/ni875 · Cited by 1,868
Self-citationDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Self-citationInterferons, interferon‐like cytokines, and their receptors
Pestka, S., Krause, C. D., & Walter, M. R. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00204.x · Cited by 1,766
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., et al. (2003) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,570
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
JAK-STAT Signaling: From Interferons to Cytokines
Schindler, C., Levy, D. E., & Decker, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700016200 · Cited by 1,258
Self-citationTargeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Self-citationDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity
Loo, Y.-M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., Akira, S., Gill, M. A., García-Sastre, A., Katze, M. G., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01080-07 · Cited by 1,071
Marie, I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6660 · Cited by 1,049
Role of deficient type III interferon-λ production in asthma exacerbations
Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A. B., Bartlett, N. W., Kebadze, T., Mallia, P., Stanciu, L. A., Parker, H. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1462 · Cited by 1,006
Self-citationKolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J., & Murali-Krishna, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050821 · Cited by 965
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
Sommereyns, C., Paul, S., Staeheli, P., & Michiels, T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000017 · Cited by 772
Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D., & Mescher, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4465 · Cited by 630
Ank, N., West, H., Bartholdy, C., Eriksson, K., Thomsen, A. R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4501-4509.2006 · Cited by 596
Marcello, T., Grakoui, A., Barba–Spaeth, G., Machlin, E. S., Kotenko, S. V., Macdonald, M. R., & Rice, C. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.052 · Cited by 561
Self-citationGilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X.-L., Trinchieri, G., O'Garra, A., & Liu, Y.-J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020045 · Cited by 524
Zhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L., & Hartmann, R. (2007) · Journal of Virology · doi:10.1128/jvi.02438-06 · Cited by 479
Triggering the Innate Antiviral Response through IRF-3 Activation
Hiscott, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700002200 · Cited by 458
Spann, K. M., Tran, K.-C., Chi, B., Rabin, R. L., & Collins, P. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4363-4369.2004 · Cited by 447
An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity
Ank, N., Iversen, M. B., Bartholdy, C., Staeheli, P., Hartmann, R., Jensen, U. B., Dagnaes-Hansen, F., Thomsen, A. R., Chen, Z., Haugen, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2474 · Cited by 419
Immune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
Self-citationHonda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934678100 · Cited by 361
Wikenheiser, K. A., Vorbroker, D. K., Rice, W. R., Clark, J. C., Bachurski, C. J., Oie, H. K., & Whitsett, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11029 · Cited by 358
Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism
Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608618200 · Cited by 355
Doyle, S. E., Schreckhise, H., Khuu‐Duong, K., Henderson, K., Rosler, R., Storey, H., Yao, L., Liu, H., Barahmand‐pour, F., Sivakumar, P., et al. (2006) · Hepatology · doi:10.1002/hep.21312 · Cited by 348
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Österlund, P. I., Pietilä, T. E., Veckman, V., Kotenko, S. V., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3434 · Cited by 301
Self-citationDumoutier, L., Tounsi, A., Michiels, T., Sommereyns, C., Kotenko, S. V., & Renauld, J.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404789200 · Cited by 291
Self-citationThe Role of Interferon in Influenza Virus Tissue Tropism
García-Sastre, A., Durbin, R. K., Zheng, H., Palese, P., Gertner, R., Levy, D. E., & Durbin, J. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8550-8558.1998 · Cited by 286
Self-citationLasfar, A., Lewis-Antes, A., Smirnov, S. V., Anantha, S., Abushahba, W., Tian, B., Reuhl, K., Dickensheets, H., Sheikh, F., Donnelly, R. P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3653 · Cited by 254
Self-citationThe Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice
Price, G. E., Gaszewska-Mastarlarz, A., & Moskophidis, D. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3996-4003.2000 · Cited by 192
Österlund, P., Veckman, V., Sirén, J., Klucher, K. M., Hiscott, J., Matikainen, S., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9608-9617.2005 · Cited by 183
Wang, J., Oberley-Deegan, R., Wang, S., Nikrad, M., Funk, C. J., Hartshorn, K. L., & Mason, R. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1296 · Cited by 174
Matikainen, S., Sirén, J., Tissari, J., Veckman, V., Pirhonen, J., Severa, M., Sun, Q., Lin, R., Meri, S., Uzé, G., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3515-3522.2006 · Cited by 173
Jewell, N. A., Vaghefi, N., Mertz, S. E., Akter, P., Peebles, R. S., Bakaletz, L. O., Durbin, R. K., Flaño, E., & Durbin, J. E. (2007) · Journal of Virology · doi:10.1128/jvi.00530-07 · Cited by 172
Self-citationInfluenza A Virus Strains Differ in Sensitivity to the Antiviral Action of Mx-GTPase
Dittmann, J., Stertz, S., Grimm, D. G., Steel, J., García‐Sastre, A., Haller, O., & Kochs, G. (2008) · Journal of Virology · doi:10.1128/jvi.01753-07 · Cited by 157
Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases
Bustamante, J. C., Boisson‐Dupuis, S., Jouanguy, E., Pïcard, C., Puel, A., Abel, L., & Casanova, J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.005 · Cited by 154
Schulman, J. L., & Palese, P. (1977) · Journal of Virology · doi:10.1128/jvi.24.1.170-176.1977 · Cited by 140
Prakash, A., Smith, E., Lee, C., & Levy, D. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501289200 · Cited by 131
Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo
Gil, M. P., Salomon, R., Louten, J., & Biron, C. A. (2005) · Blood · doi:10.1182/blood-2005-07-2834 · Cited by 124
Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector
Martínez‐Sobrido, L., Gitiban, N., Fernández-Sesma, A., Cros, J. F., Mertz, S. E., Jewell, N. A., Hammond, S., Flaño, E., Durbin, R. K., García‐Sastre, A., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1130-1139.2006 · Cited by 123
Self-citationSirén, J., Imaizumi, T., Sarkar, D., Pietilä, T. E., Noah, D. L., Lin, R., Hiscott, J. B., Krug, R. M., Fisher, P. B., Julkunen, I., et al. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.02.028 · Cited by 113
Full house: 12 receptors for 27 cytokines
Kotenko, S. V., & Langer, J. A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.003 · Cited by 109
Self-citationChi, B., Dickensheets, H. L., Spann, K. M., Alston, M. A., Luongo, C., Dumoutier, L., Huang, J., Renauld, J., Kotenko, S. V., Roederer, M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5032-5040.2006 · Cited by 109
Self-citationBerghäll, H., Sirén, J., Sarkar, D., Julkunen, I., Fisher, P. B., Vainionpää, R., & Matikainen, S. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.04.005 · Cited by 106
Protective role of interferon-induced Mx GTPases against influenza viruses
Haller, O., Staeheli, P., & Kochs, G. (2009) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.28.1.1867 · Cited by 105
Sugiura, A., & Ueda, M. (1980) · Virology · doi:10.1016/0042-6822(80)90457-2 · Cited by 86
Daly, K. R., Nguyen, P., Woodland, D. L., & Blackman, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7416-7422.1995 · Cited by 84
Role for Innate IFNs in Determining Respiratory Syncytial Virus Immunopathology
Johnson, T. R., Mertz, S. E., Gitiban, N., Hammond, S., LeGallo, R., Durbin, R. K., & Durbin, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7234 · Cited by 75
Self-citationFrom interference to interferon: a brief historical introduction
Lindenmann, J.-M. (1982) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1982.0101 · Cited by 38
Chimeric Influenza A Viruses with a Functional Influenza B Virus Neuraminidase or Hemagglutinin
Flandorfer, A., García‐Sastre, A., Basler, C. F., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9116-9123.2003 · Cited by 36
Cited by
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
“However, mounting evidence suggests that each type of IFN might have a non-redundant role in host defense or immunopathology, particularly at epithelial barriers (Broggi et al., 2020; Iwasaki et al., 2017; Iwasaki and Pillai, 2014; Jewell et al., 2010).”
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Major, J., Crotta, S., Llorian, M., McCabe, T. M., Gad, H. H., Priestnall, S. L., Hartmann, R., & Wack, A. (2020) · Science · doi:10.1126/science.abc2061 · Cited by 503
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Lazear, H. M., Nice, T. J., & Diamond, M. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.001 · Cited by 480
Newton, A. H., Cardani, A., & Braciale, T. J. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0558-0 · Cited by 476
Metadata
- Authors
- Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., & Durbin, J. E.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-11
- Volume
- 84
- Issue
- 21
- Pages
- 11515-11522
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2053341712
- Cited by
- 263
- References
- 56
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.